BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2017 4:24:48 AM | Browse: 1325 | Download: 2373
Publication Name World Journal of Clinical Oncology
Manuscript ID 33609
Country United States
ISSN 2218-4333 (online)
Open Access This article is an open-access article which was selected by an in house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Stereotactic radiotherapy for prostate cancer: A review and future directions
Manuscript Source Invited Manuscript
All Author List Yusef A Syed, Ami K Patel-Yadav, Charlotte Rivers and Anurag K Singh
Funding Agency and Grant Number
Corresponding Author Anurag K Singh, Professor, Department of Radiation Oncology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, United States. anurag.singh@roswellpark.org
Key Words Stereotactic body radiotherapy; Prostate cancer; Radiation therapy; Hypofractionation; Toxicity; Stereotactic ablative radiotherapy
Core Tip Initial studies examining the use of stereotactic body radiotherapy (SBRT) in the treatment of prostate cancer have demonstrated impressive rates of biochemical recurrence-free survival and prostate specific antigen response, while maintaining a relatively favorable acute toxicity profile. Here we review a number of recent prospective and retrospective studies to evaluate the efficacy and toxicity of SBRT in the treatment of low, intermediate, and high-grade prostate cancer.
Publish Date 2017-09-25 04:24
Citation Syed YA, Patel-Yadav AK, Rivers C, Singh AK. Stereotactic radiotherapy for prostate cancer: A review and future directions. World J Clin Oncol 2017; 8(5): 389-397
URL http://www.wjgnet.com/2218-4333/full/v8/i5/389.htm
DOI http://dx.doi.org/10.5306/wjco.v8.i5.389
Full Article (PDF) WJCO-8-389.pdf
Full Article (Word) WJCO-8-389.doc